Cellular Stress Reactions During Graft-versus-host Disease
NCT04558788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2023-12-05
Summary
This study has the aim to analyze intestinal expression of cellular stress molecules in patients with intestinal GVHD. Patients with colitis and patients without intestinal inflammation will serve as controls.
Conditions
- Graft Vs Host Disease
- Graft Versus Host Disease
Interventions
- DIAGNOSTIC_TEST
-
Immunohistochemistry on intestinal biopsies
Immunohistochemistry will be performed on human intestinal biopsies
Sponsors & Collaborators
-
University of Freiburg
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Germany
Study Locations
More Related Trials
-
CD Patients Immune Status Evaluation
NCT04135482 ·Status: COMPLETED
-
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543 ·Status: COMPLETED
-
The Diagnostic Methods of Early Postoperative Flare-up of Crohn's Disease
NCT02578576 ·Status: UNKNOWN
-
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease
NCT01288053 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pathogenic Study of Adult Immune Enteropathies
NCT04280510 ·Status: RECRUITING
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
NCT02770495 ·Status: COMPLETED ·Phase: PHASE3
-
Endomicroscopy in IBD Patients
NCT01417728 ·Status: COMPLETED
-
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599 ·Status: COMPLETED ·Phase: NA
-
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
NCT01364896 ·Status: COMPLETED
-
Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases
NCT02735941 ·Status: COMPLETED
-
Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease
NCT00278577 ·Status: TERMINATED ·Phase: PHASE1
-
ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment
NCT05414552 ·Status: COMPLETED
-
Prevalence of Lymphoma in IBD
NCT00577538 ·Status: COMPLETED
-
Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
NCT03182166 ·Status: COMPLETED ·Phase: PHASE2
-
Intestinal Biomarker Analysis After ECP for ICI Colitis
NCT06074874 ·Status: COMPLETED
-
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
NCT01804166 ·Status: COMPLETED ·Phase: PHASE4
-
The Innate Immune Response and Enteric Nervous System in Crohn's Disease.
NCT06485193 ·Status: TERMINATED
-
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis
NCT06895252 ·Status: RECRUITING ·Phase: NA
-
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
NCT05702879 ·Status: RECRUITING
-
Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.
NCT02225795 ·Status: WITHDRAWN ·Phase: NA
-
Retrospective Data Analysis in Crohn's Disease
NCT01363427 ·Status: COMPLETED
-
A Diagnostic Accuracy Study Testing Fecal Biomarkers In Comparison To Endoscopic Examination
NCT04849936 ·Status: UNKNOWN
-
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
NCT00783575 ·Status: WITHDRAWN
-
Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis
NCT02277470 ·Status: UNKNOWN